title: Should we use ADRB2 variation to stratify asthma treatment?
authors.affiliation: University of Nottingham Medical School, Queens Medical Centre, Nottingham NG7 2UH, UK. Electronic address: ian.hall@nottingham.ac.uk.
authors.forename: Ian P
authors.initials: IP
authors.lastname: Hall
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D001741:Black or African American / Q000235:genetics*; D001249:Asthma / Q000235:genetics*; D005260:Female; D006630:Hispanic or Latino / Q000235:genetics*; D006801:Humans; D008297:Male; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics*; D044465:White People / Q000235:genetics*
chemical_list: D000318:Adrenergic beta-Agonists; D018343:Receptors, Adrenergic, beta-2